Clinical Features And Treatment Outcomes Of Lassa Fever Among Patients In A Tertiary Health Facility In Benue State, Nigeria:A Retrospective Study
Keywords:
Clinical features, Health facility, Lassa fever, Patients, Retrospective study, Treatment OutcomeAbstract
There is a silent predator in the heart of West Africa that lurks in the shadows of rural communities, periodically emerging to wreak havoc on human lives and healthcare systems. This formidable foe is Lassa fever, a viral hemorrhagic illness that has become synonymous with fear and urgency in Nigeria's public health landscape. This study aimed at assessing the
clinical features and treatment outcomes of Lassa Fever among Patients in a Tertiary Health Facility in Benue State, Nigeria. This was a retrospective, descriptive hospital-based research encompassing January 2022 to March 2024. Medical records of those admitted for treatment at the Benue State University Teaching Hospital were reviewed. The relevant data was coded and analyzed using IBM SPSS version 23. Data obtained showed that 219 persons were hospitalized for suspected or probable Lassa fever throughout the study period while 85 of them were confirmed positive for Lassa fever giving an incidence rate of 38.8%. Findings from the study showed that there were 105(47.9%) males and 114 (52.1%) females. The treatment outcome showed that 78(35.6%) survived and were discharged, 108(49.3%) were referred to other facilities for dialysis and 33 (15.1%) patients died, giving a mortality rate of 15.1%. The common clinical features were abnormal bleeding, myalgia, retrosternal pain, cough, abdominal pain, malaise, nausea, vomiting, fever, headache, and sore throat. Laboratory indices showed that 110 (50.2%) of them had impaired liver function while 109 (49.8%) showed normal liver function. The RT-PCR for Lassa fever virus was positive in 85(38.8%) whereas 85(38.4%) of the patients had haematuria, 61(27.9%) of them had proteinuria and 67(30.6%) had both haematuria and proteinuria on urinalysis.
References
1. World Health Organization—Lassa Fever outbreak news. Available online: https://www.who.int/emergencies/disease-outbreak-news/item/lassa-fever---nigeria accessed on the 22nd of January 2026.
2. Cadmus S, Akinseye V, Cadmus E, Famokun G, Fagbemi S, Ogunde G, et al. Drivers of Lassa fever in an endemic area of southwestern Nigeria (2017–2021): An epidemiological study. (2025) PLoS One 20(6): e0327143. https://doi.org/10.1371/journal.pone.0327143.
3. Olayinka AT, Elimian K, Ipadeola O, Dan-Nwafor C, Gibson J, Ochu C, et al. Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria. PLOS Glob Public Health. 2022;2(8): e0000191. https://doi.org/10.1371/journal.pgph.0000191
4. Centers for Disease Control and Prevention Imported Lassa fever—New Jersey, 2004 MMWR Morb Mortal Weekly Rep. 2004;53:894-897
https://www.cdc.gov/lassa-fever/about/index.html NICD.
5. WHO. Lassa Fever. 2017. Available from: https://www.who.int/news-room/fact-sheets/detail/lassa-fever Accessed on the 20th of February 2026
6. Newman T. Everything you need to know about lassa fever. Medical News Today (2018). 2018. [cited 2021 Apr 21] Available from:https://www.medicalnewstoday.com/articles/306886
7. NICD. Lassa fever disease. Lassa fever report: Division of the national health laboratory service. 2021. Available from: https://www.nicd.ac.za/diseases-a-z-index/lassa-fever/
8. Yun NE, Walker DH. Pathogenesis of Lassa fever. Viruses. 2021;4(10):2031–48.
9. Viral hemorrhagic fevers consortium: Lassa fever. VHFC; 2013. Available at: http://www.vhfc.org/lassa_fever (accessed Jan, 2026).
10. Azuka PO, Chizaram AO, Obiageli TO, Muritala O S, Samirah N A, Ezekwelu NJ, et al. Clinical outcomes of severe Lassa fever in West Africa: A Systematic Review and Meta-Analysis; Int. J. Environ. Res. Public Health 2025; 22(10):1504. https://doi.org/10.3390/ijerph22101504
11. Adebola T. Olayinka, Kelly Elimian, Oladipupo Ipadeola, Chioma Dan-Nwafor, et al. Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria: August 26, 2022. https://doi.org/10.1371/journal.pgph.0000191
12. Mbaave TP, Ogbu O, Echekwube PO, Swende TZ, Igbah IT. Lassa Fever: Patients Profile and Treatment Outcomes at Benue State University Teaching Hospital Makurdi, North-Central Nigeria. Advances in Infectious Diseases. 2023;13(4), 722-734.
14. Oboratare O, Chukwuyem A, Emmanuel O, Obekpa AS. Housing factors and transmission of Lassa fever in a rural area of south-South Nigeria. General Health and Medical Sciences. 2014;1(2), 15-20.
15. Shehu NY, Gomerep SS, Isa SE, Iraoyah KO, Mafuka J, Bitrus & Paessler S. Lassa fever 2016 outbreak in Plateau State, Nigeria—The changing epidemiology and clinical presentation. Frontiers in Public Health. 2018;6:232.
16. Ehichioya DU, Asogun DA, Ehimuan J, Okokhere PO, Pahlmann M, Ölschläger S, Omilabu SA. Hospital‐based surveillance for Lassa fever in Edo State, Nigeria, 2005–2008. Tropical Medicine & International Health. 2012;17(8), 1001-1004.
17. Ochu C L, Ntoimo L, Onoh I, Okonofua F, Meremikwu M, Mba S. et al. Predictors of Lassa fever diagnosis in suspected cases reporting to health facilities in Nigeria. Scientific reports. 2023;13(1), 6545.
18. Malik S, Bora J, Dhasmana A, Kishore S, Nag S, Preetam S, et al. An update on current understanding of the epidemiology and management of the re-emerging endemic Lassa fever outbreaks. International Journal of Surgery. 2023;109(3), 584-586.
19. Okokhere P, Colubri A, Azubike C, Iruolagbe C, Osazuwa O, Tabrizi S, et al. Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: A retrospective, observational cohort study. The Lancet Infectious Diseases. 2018;18(6), 684–695.
20. Izah S C, Ovuru KF, Ogwu MC. Lassa fever in Nigeria: Social and ecological risk factors exacerbating transmission and sustainable management strategies. International Journal of Tropical Diseases. 2022;5(2), 065.
